Skip to content

A clinical Study to Assess the safety and Efficacy of COCOZEN as a sports performance supplement in Healthy athletes

A randomized Double blind comparative cross over pilot study to evaluate the efficacy and safety of COCOZEN as a sports performance and physical endurance enhancement supplement in healthy volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012551
Enrollment
48
Registered
2018-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: COCOZEN: COCOZEN dissolved in 100ml of water consumed prior to the exercise every day for 21 days Control Intervention1: Water: 100ml of water Consumed prior to the exercise everyday fo

Sponsors

Akay Flavours and Aromatics Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age 21-35yrs 2) Male 3) physically fit with a body weight between 50-80 k g 4) Athletets (Runners ,swimmers and weight lifters etc) have at least 6 month prior training experience 5) Subject should agree to avoid vitamins, minerals or any kind of performance enhancing supplements during the study period 6) Subject should agree to avoid any kind of physical exercise 24 hours prior to the scheduled visit 7) Subject should agree to avoid alcohol from 3 days prior to each visit 8) Subject should ready to sign the informed consent and should comply with the written protocol

Exclusion criteria

Exclusion criteria: 1) Subject with history of cardiovascular, pulmonary, hepatic and renal problems 2) Subjects who are currently under any kind of long term medication 3) Subjects who have taken steroids or any kind of performance enhancing ingredients in the last 3 months 4) Subjects with a known allergy to herbal products 5) Chronic drinkers 6) Subject with a habit of smoking 7) Subjects with abnormal blood pressure 8) Subjects who had a muscle injury and taken medication within last one month 9) Subjects with a history of orthopaedic problems 10) Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study

Design outcomes

Primary

MeasureTime frame
Effect of COCOZEN on energy, recovery, inflammation, muscle damage recovery, increase in physical endurance, agility and balanceTimepoint: Day 0, Day 21,Day 42

Secondary

MeasureTime frame
Effect of COCOZEN on Oxidative stress, Antioxidant enzymes, Inflammatory markersTimepoint: Day 0, Day 21,Day 42

Countries

India

Contacts

Public ContactJestin V Thomas

Akay Flavours and Aromatics Private Limited

Krishnakumar.IM@akay-group.com04842686111

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026